Several studies reported an association between nonalcoholic fatty liver disease (NAFLD)
and the risk of incident hypertension. The objective of this systematic review and meta …

Abstract Background & Aims Liver stiffness is an indirect marker of liver fibrosis, which
predicts clinical outcomes in patients with nonalcoholic fatty liver disease (NAFLD). The aim …

An association between liver stiffness, a surrogate measure of liver fibrosis, and chronic
kidney disease (CKD) in patients with nonalcoholic fatty liver disease (NAFLD) has been …

Data are limited on the epidemiological implications of the recent change in terminology
from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction‐associated fatty liver …

OBJECTIVE Type 2 diabetes mellitus (T2DM) is an important risk factor for the progression
of metabolic liver disease to advanced fibrosis. Here, we provide an estimate of the …

Abstract Background and Objective The aim of the present study is to explore the
epidemiologic impact of the definition of steatotic liver disease (SLD) proposed by a multi …

Background Few population-based studies have investigated the association between body
fat distribution and the risk of nonalcoholic fatty liver disease (NAFLD) and significant liver …

Background & Aims Metabolic-associated fatty liver disease (MAFLD) is common among
adolescents, but the prevalence of significant fibrosis in this age group is not known. We …

Context Serum neurofilament light chain (sNfL) levels are biomarkers of neuroaxonal injury
in multiple neurological diseases. Objective Given the paucity of data on the distribution of …

Objective Non-alcoholic fatty liver disease (NAFLD) is prevalent in patients with type 2
diabetes. Here, we estimate the proportion of patients with type 2 diabetes that should be …